{ "format" : "linked-data-api", "version" : "0.2", "result" : {"_about" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&max-AnswerDate=2021-06-09&houseId=2", "definition" : "https://eldaddp.azurewebsites.net/meta/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&max-AnswerDate=2021-06-09&houseId=2", "extendedMetadataVersion" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&max-AnswerDate=2021-06-09&houseId=2&_metadata=all", "first" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&_page=0&max-AnswerDate=2021-06-09&houseId=2", "hasPart" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&max-AnswerDate=2021-06-09&houseId=2", "isPartOf" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&max-AnswerDate=2021-06-09&houseId=2", "items" : [{"_about" : "http://data.parliament.uk/resources/1328015", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1328015/answer", "answerText" : {"_value" : "<p>The B.1.351 COVID-19 variant was categorised as a variant of concern (VOC) on 23 December 2020 by the New and Emerging Respiratory Virus Threats Advisory Group. The decision to raise this lineage to a VOC was taken on the basis of reports indicating that the strain had replaced pre-existing strains in parts of South Africa and that there were two cases of B.1.351 identified in the United Kingdom with links to travel from South Africa. The genetic variations identified in the spike protein of B.1.351 were also cause for concern.<\/p><p>The three substitutions in the receptor binding domain, and in particular the E484K substitution, were thought to result in weaker neutralisation by some monoclonal antibodies and polyclonal neutralising sera. Although at the time there was no formal modelling from South Africa, the rapid spread of the variant could be consistent with increased transmissibility, which was also biologically plausible. More recent data has shown that B.1.351 has greater transmissibility than the original Wuhan strains of the virus. Evaluation was at an early stage when the recommendation to escalate this lineage was taken. A copy of PHE Risk assessment for SARS-CoV-2 variant: VOC-202012/02 (origin: South Africa) of 23 December is attached.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Bethell"}
        , "attachment" : {"_about" : "http://data.parliament.uk/resources/1328015/answer/attachment/1", "fileName" : {"_value" : "HL580 20201223_VOC-202012 02_SARS-COV-2 variant risk assessment tool_v2.0.docx"}
          , "title" : "PHE Risk assessment for SARS-CoV-2 variant"}
        , "dateOfAnswer" : {"_value" : "2021-06-03", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-06-03T11:13:19.727Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-05-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Coronavirus"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government whether they will publish the latest evidence base which has led to the B1.351 COVID-19 variant being categorised as a variant of concern, particularly in regard to its transmissibility.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4549", "label" : {"_value" : "Biography information for Lord Oates"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Oates"}
      ], "uin" : "HL580"}
    , {"_about" : "http://data.parliament.uk/resources/1328016", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1328016/answer", "answerText" : {"_value" : "<p>Public Health England (PHE) is researching the effectiveness of the Pfizer and AstraZeneca vaccines against the B1.351 variant. PHE will publish advice in the weekly COVID-19 vaccine surveillance report once sufficient data is available.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Bethell"}
        , "dateOfAnswer" : {"_value" : "2021-06-10", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-06-10T11:56:58.973Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-05-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Coronavirus: Vaccination"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what scientific evidence they have on the effectiveness of the (1) Pfizer, and (2) Astra Zeneca, vaccines in reducing (a) hospitalisations, and (b) symptomatic infections, linked to the B1.351 COVID-19 variant; and what plans they have to publish this evidence.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4549", "label" : {"_value" : "Biography information for Lord Oates"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Oates"}
      ], "uin" : "HL581"}
    , {"_about" : "http://data.parliament.uk/resources/1328017", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1328017/answer", "answerText" : {"_value" : "<p>The United Kingdom has large-scale sequencing capacity and extensive specialist expertise and is uniquely positioned to help address global sequencing capability gaps. Through the New Variant Assessment Platform (NVAP) programme, Public Health England (PHE) will work to support global partners to strengthen their genomic sequencing capability, either by building on existing infrastructure or by conducting sequencing and analysis of samples in the UK if there is no in-country capability.<\/p><p>The NVAP will also enable the biological assessment of emerging variants, strengthening horizon scanning and public health decision-making, both in this country and abroad. This includes a risk assessment from the point when a mutation is first identified, to ongoing assessment as more information becomes available. The platform will also agree pathways for biological analysis, diagnostics, vaccines and therapeutics as appropriate. PHE is working with the Africa Centres for Disease Control and Prevention to deploy a Technical Advisor for regional level support.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Bethell"}
        , "dateOfAnswer" : {"_value" : "2021-06-03", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-06-03T10:08:50.253Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-05-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Coronavirus: Screening"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government what steps they are taking to cooperate with the scientific community of South Africa on genomic sequencing relating to COVID-19.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4549", "label" : {"_value" : "Biography information for Lord Oates"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Oates"}
      ], "uin" : "HL582"}
    , {"_about" : "http://data.parliament.uk/resources/1328021", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1328021/answer", "answerText" : {"_value" : "<p>We recognise the vital role all unpaid carers play, especially during this difficult period and are committed to supporting carers to provide care as they would wish, and to do so in a way that supports their own health and wellbeing and other life chances.<\/p><p>The Health and Social Care Bill provides an opportunity to create a health and care system that is more accountable and responsive to the people that use it. We are committed to ensuring that the voices of unpaid carers and those who access care and support are properly embedded in the design and development of Integrated Care Systems.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Bethell"}
        , "dateOfAnswer" : {"_value" : "2021-06-10", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-06-10T12:19:40.64Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-05-25", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Carers"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government whether the forthcoming Health and Social Care Bill will make provision relating to unpaid carers.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/457", "label" : {"_value" : "Biography information for Lord Pendry"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Pendry"}
      ], "uin" : "HL586"}
    , {"_about" : "http://data.parliament.uk/resources/1327196", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1327196/answer", "answerText" : {"_value" : "<p>Public Health England has not conducted any research nor conducted a review of research evidence on this topic.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Bethell"}
        , "dateOfAnswer" : {"_value" : "2021-06-02", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-06-02T12:51:16.753Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-05-24", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Protective Clothing: Health Hazards"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government whether they are aware of any research on the effects of continuous mask-wearing over long periods; and if so what are the findings of that research.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4321", "label" : {"_value" : "Biography information for Lord Farmer"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Farmer"}
      ], "uin" : "HL481"}
    , {"_about" : "http://data.parliament.uk/resources/1327209", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1327209/answer", "answerText" : {"_value" : "<p>The National Institute for Health and Care Excellence\u2019s (NICE) guideline, <em>Chronic pain (primary and secondary) in over 16s: assessment of all chronic pain and management of chronic primary pain<\/em>, published in April 2021, recommends a range of pharmacological and non-pharmacological treatment options for pain management. NICE found there was insufficient evidence on mindfulness to recommend it as an option for pain management within this guideline. However, it made recommendations for research on mindfulness to inform future guidance. A copy of NICE\u2019s guideline is attached.<\/p><p>The National Health Service is also taking a holistic approach to supporting people\u2019s health and wellbeing by expanding its social prescribing services. This enables general practitioners to refer people to community groups and agencies for practical, emotional and social support, for example when managing pain.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Bethell"}
        , "attachment" : {"_about" : "http://data.parliament.uk/resources/1327209/answer/attachment/1", "fileName" : {"_value" : "NICE Chronic Pain Guidance (1).pdf"}
          , "title" : "NICE Guideline"}
        , "dateOfAnswer" : {"_value" : "2021-06-21", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-06-21T11:10:11.983Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-05-24", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Pain"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government how they will ensure that those seeking support for managing pain are offered a choice of options through the NHS including mindfulness-based therapies, to reduce the proportion of treatments that rely on medication and the risk of overprescribing.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4179", "label" : {"_value" : "Biography information for Baroness Healy of Primrose Hill"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Healy of Primrose Hill"}
      ], "uin" : "HL498"}
    , {"_about" : "http://data.parliament.uk/resources/1327216", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1327216/answer", "answerText" : {"_value" : "<p>Public Health England has not made a formal assessment.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Bethell"}
        , "dateOfAnswer" : {"_value" : "2021-06-03", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-06-03T10:45:19.793Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-05-24", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Vitamin D"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government, further to the Written Answer by Lord Bethell on 1 February (HL12508), what assessment they have made of the recommendation of the Irish Joint Committee on Health for people in that country to take a daily dose of Vitamin D at least two times higher than the dose recommended by Public Health England; and what steps they intend to take as a result.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/4234", "label" : {"_value" : "Biography information for Baroness Lister of Burtersett"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Baroness Lister of Burtersett"}
      ], "uin" : "HL512"}
    , {"_about" : "http://data.parliament.uk/resources/1327218", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1327218/answer", "answerText" : {"_value" : "<p>Re-configuring service delivery to ensure sufficient National Health Service capacity was central to our preparedness for a pandemic and the COVID-19 response. However, the Department does not have - and did not have in January 2020 - a pandemic triage policy for hospitals and care homes, as this is a clinical matter. In the event that patient triage becomes necessary, clinical guidance would be produced to support decision-making.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Bethell"}
        , "dateOfAnswer" : {"_value" : "2021-06-30", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-06-30T13:10:38.38Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-05-24", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Coronavirus: Disease Control"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government which documents set out the triage policy in relation to a pandemic for (1) hospitals, and (2) care homes, as of January 2020.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1387", "label" : {"_value" : "Biography information for Lord Mann"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Mann"}
      ], "uin" : "HL514"}
    , {"_about" : "http://data.parliament.uk/resources/1327220", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1327220/answer", "answerText" : {"_value" : "<p>During the last year, the government agreed a number of measures to improve the finances in the NHS provider sector in England. These included writing off £13.4 billion of NHS debt, as part of a major financial reset for NHS providers; temporary arrangements that saw trusts receive block payments to fund their spending through the pandemic, supported by c£18bn of additional funding to support the NHS response to COVID. As a result, the amount and levels of deficits across in the NHS provider sector fell significantly.<\/p><p>Work is ongoing to support the minority of trusts who ended 2020/21 in a deficit position and to develop solutions to secure future financial sustainability.<\/p><p>Final deficit figures for 2020-21 will be published as part of the NHS\u2019s final accounts in due course.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Bethell"}
        , "dateOfAnswer" : {"_value" : "2021-06-07", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-06-07T14:13:49.807Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-05-24", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Hospitals: Debts"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government which 10 UK hospitals have the highest financial deficit, including debts carried over from previous years.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/1387", "label" : {"_value" : "Biography information for Lord Mann"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Mann"}
      ], "uin" : "HL516"}
    , {"_about" : "http://data.parliament.uk/resources/1327226", "AnsweringBody" : [{"_value" : "Department of Health and Social Care"}
      ], "answer" : {"_about" : "http://data.parliament.uk/resources/1327226/answer", "answerText" : {"_value" : "<p>The Department is aware of ongoing supply issues resulting in intermittent availability of diamorphine injections, due to manufacturing issues. Further supplies of diamorphine injections are expected to be available in June. The Department continues to work closely with all suppliers and the National Health Service to maintain supply to patients who require it. The Department has communicated this issue to the NHS, advising the need to move to alternative opioids where diamorphine is currently used.<\/p>"}
        , "answeringMember" : {"_about" : "http://data.parliament.uk/members/4708", "label" : {"_value" : "Biography information for Lord Bethell"}
        }
        , "answeringMemberPrinted" : {"_value" : "Lord Bethell"}
        , "dateOfAnswer" : {"_value" : "2021-06-02", "_datatype" : "dateTime"}
        , "isMinisterialCorrection" : {"_value" : "false", "_datatype" : "boolean"}
        , "questionFirstAnswered" : [{"_value" : "2021-06-02T12:49:18.413Z", "_datatype" : "dateTime"}
        ]}
      , "answeringDeptId" : {"_value" : "17"}
      , "answeringDeptShortName" : {"_value" : "Health and Social Care"}
      , "answeringDeptSortName" : {"_value" : "Health and Social Care"}
      , "date" : {"_value" : "2021-05-24", "_datatype" : "dateTime"}
      , "hansardHeading" : {"_value" : "Diamorphine"}
      , "houseId" : {"_value" : "2"}
      , "legislature" : [{"_about" : "http://data.parliament.uk/terms/25277", "prefLabel" : {"_value" : "House of Lords"}
      }
      ], "questionText" : "To ask Her Majesty's Government, further to the Written Answer by Lord Bethell on 29 April (HL15336), what assessment they have made of the supply of diamorphine; what steps they are taking to ensure that any shortage in the availability of diamorphine to NHS patients is addressed; and when they expect any such shortage to end.", "registeredInterest" : {"_value" : "false", "_datatype" : "boolean"}
      , "tablingMember" : {"_about" : "http://data.parliament.uk/members/3153", "label" : {"_value" : "Biography information for Lord Pearson of Rannoch"}
      }
      , "tablingMemberPrinted" : [{"_value" : "Lord Pearson of Rannoch"}
      ], "uin" : "HL528"}
    ], "itemsPerPage" : 10, "next" : "https://eldaddp.azurewebsites.net/answeredquestions.text?answeringDeptShortName=Health+and+Social+Care&_page=1&max-AnswerDate=2021-06-09&houseId=2", "page" : 0, "startIndex" : 1, "totalResults" : 4153, "type" : ["http://purl.org/linked-data/api/vocab#ListEndpoint", "http://purl.org/linked-data/api/vocab#Page"]}
}